Back to top

Taysha Gene Therapies, Catalent announce commercial supply pact for TSHA-102

Taysha Gene Therapies (TSHA) and Catalent announced a commercial supply agreement for TSHA-102, Taysha’s investigational gene therapy in pivotal de...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Taysha Gene Therapies, Inc. (TSHA)